Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
International Journal of Cancer
|
March 15, 1996
Colon-cancer cell variants producing regressive tumors in syngeneic rats, unlike variants yielding progressive tumors, attach to interstitial collagens through integrin alpha2beta1
M Martin, K Ahlen, M T Dimanche-Boitrel, et al.
Cancer Research
|
May 15, 1992
Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo
P Genne, M T Dimanche-Boitrel, R Y Mauvernay, et al.
British Journal of Cancer
|
October 1, 1994
Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells
M Assem, S Bonvalot, J L Beltramo, et al.
International Journal of Cancer
|
February 15, 1994
In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts
M T Dimanche-Boitrel, L Vakaet, P Pujuguet, et al.
International Journal of Cancer
|
March 12, 1992
Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells
M T Dimanche-Boitrel, H Pelletier, P Genne, et al.
Toxicology and Applied Pharmacology
|
October 31, 2009
The B[a]P-increased intercellular communication via translocation of connexin-43 into gap junctions reduces apoptosis
X Tekpli, E Rivedal, M Gorria, et al.
Oncogene
|
August 6, 2008
Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage
A Rebillard, N Rioux-Leclercq, C Muller, et al.
Cell Death and Differentiation
|
July 21, 2012
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
S Jouan-Lanhouet, M I Arshad, C Piquet-Pellorce, et al.
Scientific Reports
|
October 12, 2017
6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury
C Delehouzé, S Leverrier-Penna, F Le Cann, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
International Journal of Cancer
|
March 15, 1996
Colon-cancer cell variants producing regressive tumors in syngeneic rats, unlike variants yielding progressive tumors, attach to interstitial collagens through integrin alpha2beta1
M Martin, K Ahlen, M T Dimanche-Boitrel, et al.
Cancer Research
|
May 15, 1992
Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo
P Genne, M T Dimanche-Boitrel, R Y Mauvernay, et al.
British Journal of Cancer
|
October 1, 1994
Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells
M Assem, S Bonvalot, J L Beltramo, et al.
International Journal of Cancer
|
February 15, 1994
In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts
M T Dimanche-Boitrel, L Vakaet, P Pujuguet, et al.
International Journal of Cancer
|
March 12, 1992
Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells
M T Dimanche-Boitrel, H Pelletier, P Genne, et al.
Toxicology and Applied Pharmacology
|
October 31, 2009
The B[a]P-increased intercellular communication via translocation of connexin-43 into gap junctions reduces apoptosis
X Tekpli, E Rivedal, M Gorria, et al.
Oncogene
|
August 6, 2008
Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage
A Rebillard, N Rioux-Leclercq, C Muller, et al.
Cell Death and Differentiation
|
July 21, 2012
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
S Jouan-Lanhouet, M I Arshad, C Piquet-Pellorce, et al.
Scientific Reports
|
October 12, 2017
6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury
C Delehouzé, S Leverrier-Penna, F Le Cann, et al.
Page
of 3